Overview of Study - PowerPoint PPT Presentation

1 / 14
About This Presentation
Title:

Overview of Study

Description:

Provide Ministry of Health/international partners the descriptive information ... International Federation of Gynecology and Obstetrics (FIGO) definition of AMTSL: ... – PowerPoint PPT presentation

Number of Views:34
Avg rating:3.0/5.0
Slides: 15
Provided by: csta6
Category:
Tags: overview | study

less

Transcript and Presenter's Notes

Title: Overview of Study


1
Overview of Study Management of the Third Stage
of Labor In Uganda
2
Our ultimate goal
  • Provide Ministry of Health/international partners
    the descriptive information needed to assess
    current practices regarding active management of
    the third stage of labor (AMTSL).
  • Identify major barriers to its use.
  • In order to
  • Develop interventions to improve adoption and
    implementation of the practice of AMTSL.
  • (Secondary aim) Produce public domain tools and a
    methodology that could be employed by others in
    the future to document change.

3
International Confederation of Midwives
(ICM)/International Federation of Gynecology and
Obstetrics (FIGO) definition of AMTSL
  • Administering a uterus-contracting drug, e.g.,
    oxytocin, within one minute of birth.
  • Applying controlled cord traction and counter
    traction to the uterus.
  • Massaging uterus after delivery of the placenta,
    as appropriate.

4
Variations of the definition of AMTSL
  • Uterotonic drug some specify oxytocin (drug of
    choice), other drugs have been used in the
    literature (ergometrine, syntocinon,
    syntometrine, prostaglandins).
  • Early or immediate cord clamping not
    recommended by ICM/FIGO.
  • But for descriptive purposes we should collect
    data on what is being done.
  • Some studies have omitted uterine massage.
  • No studies to date looking at effectiveness of
    the individual components of AMTSL.

5
What does AMTSL do for a woman?
6
Evidence on AMTSL
  • Reduces incidence of postpartum hemorrhage by up
    to 60 percent.
  • Reduces the quantity of blood lossthereby
    decreasing incidence and severity of anemia.
  • Reduce emergencies and related cost, transport.
  • Reduces the use of blood transfusion.

7
To date, there has only been one study to
document AMTSL practices internationally
Bulletin of the World Health Organization (WHO),
2003
8
Source Festin et al. 2003 Bulletin of the WHO
9
However, these data
  • Are only from university teaching hospitals.
  • (one health facility in each country, so this is
    not a representative sample of deliveries in a
    country)
  • Suggest that practices vary widely. People say
    they are doing active management, but many of
    them are using different definitions.
  • Do not tell us WHY providers do or do not use
    AMTSL routinely.

10
Our study wants to describe
  • How different providers/facilities define AMTSL.
  • The barriers (and the facilitators) to routine
    use of AMTSL.

11
Determinants of the use of AMTSL
Historical precedent, influence
of leader, WHO, in-service training
National guidelines
Policy
AMTSL protocol in hospital
Expected behavior in hospital
Presence in pre-service training
Champions for use of AMTSL
Woman receives AMTSL
Provider
Knowledge, skills in AMTSL
Implementation
Motivation to use
Proper storage
Sufficient availability of oxytocics, needles, syr
inge on site
Logistics
Amount procured
Transport issues
Procure- ment at hospital level
Uterotonics included on Essential Drug
List (oxytocin drug of choice)
12
Components of the survey re use of AMTSL
Historical precedent, influence
of leader, WHO, in-service training
National guidelines
Policy
AMTSL protocol in hospital
Expected behavior in hospital
Presence in pre-service training
Champions for use of AMTSL
Woman receives AMTSL (per ICM/ FIGO Statement)
Provider
Implementation
Skills in AMTSL
Know- ledge
Motivation to use
Proper storage
Sufficient availability of oxytocics, needles, syr
inge on site
Logistics
Amount procured
Transport issues
Procure- ment at hospital level
Uterotonics included on Essential Drug
List (oxytocin drug of choice)
13
We have divided our data collection so that
  • The quantitative data has already been collected
    analysis is underway.
  • This will be the qualitative part of the study
    during which
  • You will interview health care providers about
    their attitudes and practices in AMTSL.
  • You will interview community leaders, traditional
    birth attendants, and community members about
    PPH.

14
Remember your job is only to ask questions and
record responses
  • You should NOT express your opinion about the use
    of AMTSL.
  • You should NOT discuss the details of our study
    with health care providers or other professionals
    in health care facilities.
  • Simply say that this study is to document how the
    third stage of labor is managed. We are simply
    documenting common practices.
Write a Comment
User Comments (0)
About PowerShow.com